Show results for
Refine by
Cancer Monitoring Equipment & Supplies
14 equipment items found
Manufactured by:OraSure Technologies based inBethlehem, PENNSYLVANIA (USA)
For detection and monitoring of cancers, as well as new biomarker development, a larger volume of urine can be required. Additionally, Colli-Pee® Large Volumes supports multi-omics research. Collector tubes can be pre-filled with a preservative for different urinary analytes, improving transport and storage of urine at room temperature. ...
Manufactured by:GENCURIX based inGuro-gu, SOUTH KOREA
What is early diagnosis? Early diagnosis helps people to plan ahead while they are still able to make important decisions on their care and support needs and on financial and legal ...
Manufactured by:miR Scientific, LLC based inNew York, NEW YORK (USA)
miR Scientific is a precision healthcare company committed to improving public health by transforming cancer management globally. The company’s proprietary miR Disease Management Platform® was developed to revolutionize the standard of value-based care for cancers and initially focuses on urological cancers. The initial test delivered ...
Manufactured by:Micrel Medical Devices SA based inAthens, GREECE
The Rythmic/ Mini Rythmic Perf+ is an ambulatory pump for infusions with the following delivery modes: Continuous, Volume/Time or Volume/Rate, Auto ramp, Intermittent, 25 Steps. Application areas include as example: Chemotherapy, Antobiotic therapy, Enzyme therapy and other infusion ...
by:Xiamen Spacegen Co., Ltd. based inxiamen, CHINA
Using high-throughput sequencing to test the coding regions and exon-intron junctions of five genes (MLH1, PMS2, MSH2, MSH6, EPCAM) in the germline panel, and the same five genes plus the BRAF V600E mutation in the tissue-based panel. Detection Gene:MMR-related genes MLH1, MSH2, MSH6, PMS2 and EPCAM, BRAF gene V600E mutation. Detection Significance:Germline test as confirmed diagnosis of Lynch ...
Manufactured by:INOVIQ Ltd based inNotting Hill, AUSTRALIA
INOVIQ’s NETs technology is a sample preparation platform with the potential to revolutionise the performance of liquid biopsy diagnostic assays. The market potential for liquid biopsy applications is estimated at billions of dollars ...
Manufactured by:Pacific Edge Ltd based inDunedin,, NEW ZEALAND
Cxbladder is a non-invasive genomic urine test that quickly and accurately detects or rules out bladder cancer. The tests works at a molecular level, measuring five biomarker genes to detect the presence or absence of bladder cancer1, and comes as a suite of three product variations, each optimised for a different point in the patient ...
Manufactured by:CTIBiotech based inMeyzieu, FRANCE
Although much is known about the appearance, growth and spread of cancer in the human body, effective and rapid treatments for many cancer types are yet to be found. Chemo- and radio- therapies have made much progress in the last 20 years, but many such therapies are non-specific, leaving the patient to deal with severe side effects of the therapy and organ damage through cancer cell ...
Manufactured by:Olympia Diagnostics, Inc. based inSunnyvale, CALIFORNIA (USA)
A prognostic test kit quantitatively measures the expression levels of a panel of metastasis-specific biomarkers in patient urine sample or biopsy tissue sample to detect existing metastatic prostate cancer and predict prostate cancer that will become metastatic in the ...
Manufactured by:Olympia Diagnostics, Inc. based inSunnyvale, CALIFORNIA (USA)
A prognostic test kit quantitatively measures the expression levels of a panel of cancer recurrence-associated biomarkers in patient urine sample or biopsy tissue sample to predict cancer recurrence and patient ...
Manufactured by:Creatv MicroTech, Inc. based inRockville, MARYLAND (USA)
Personalized Cancer Therapy and Disease Monitoring: “Liquid biopsy” using circulating tumor cells (CTCs) is potentially a minimally invasive alternative to traditional tissue biopsy to determine cancer therapy. Enumeration of CTCs may be used to indicate prognosis and to monitor treatment. ...
Manufactured by:Datar Cancer Genetics based inGuildford, UNITED KINGDOM
CancertrackTM is a non-invasive blood based investigation that detects cancer derived biomarkers with ultra-high precision, specificity and reliability. CancertrackTM can be used to monitor the disease /recurrence or changes in the tumor characteristics, as often as necessary, without the cost, risk and consequences of radiation from scans, hospitalisation, ...
by:Natera, Inc. based inAustin, TEXAS (USA)
Signatera is a personalized, tumor-informed assay optimized to detect circulating tumor DNA (ctDNA) for molecular residual disease (MRD) assessment and recurrence monitoring for patients previously diagnosed with cancer, with broad utility for cancer ...
Manufactured by:OncoDNA S.A. based inGosselies, BELGIUM
OncoSELECT: Smart liquid biopsy panels with selected key genes per tumor type. The Liquid Biopsy Solution For Disease Monitoring Or Therapeutic Decision. OncoSELECT is a fast and minimally invasive analysis of circulating tumor DNA from a blood sample for lung (NSCLC), colorectal and breast (HR+ or HER2+) cancer patients. It is the perfect solution to identify ...